108950,1,Admission,O
108950,1,Date,O
108950,1,:,O
108950,1,[,O
108950,1,**2179-3-8**,O
108950,1,],O
108950,1,Discharge,O
108950,1,Date,O
108950,1,:,O
108950,1,[,O
108950,1,**2179-3-14**,O
108950,1,],O
108950,1,Date,O
108950,1,of,O
108950,1,Birth,O
108950,1,:,O
108950,1,[,O
108950,1,**2110-3-4**,O
108950,1,],O
108950,1,Sex,O
108950,1,:,O
108950,1,F,O
108950,1,Service,O
108950,1,:,O
108950,1,MEDICINE,O
108950,1,Allergies,O
108950,1,:,O
108950,1,Naproxen,B-Drug
108950,1,/,O
108950,1,Codeine,B-Drug
108950,1,/,O
108950,1,Aspirin,B-Drug
108950,1,/,O
108950,1,Oxycontin,B-Drug
108950,1,Attending,O
108950,1,:,O
108950,1,[,O
108950,1,**First,O
108950,1,Name3,O
108950,1,(,O
108950,1,LF,O
108950,1,),O
108950,1,4373**,O
108950,1,],O
108950,1,Chief,O
108950,1,Complaint,O
108950,1,:,O
108950,1,dyspnea,O
108950,1,Major,O
108950,1,Surgical,O
108950,1,or,O
108950,1,Invasive,O
108950,1,Procedure,O
108950,1,:,O
108950,1,Patient,O
108950,1,expired,O
108950,1,.,O
108950,1,History,O
108950,1,of,O
108950,1,Present,O
108950,1,Illness,O
108950,1,:,O
108950,1,Mrs.,O
108950,1,[,O
108950,1,**Known,O
108950,1,lastname,O
108950,1,10220**,O
108950,1,],O
108950,1,is,O
108950,1,a,O
108950,1,69,O
108950,1,yo,O
108950,1,F,O
108950,1,with,O
108950,1,breast,B-Reason
108950,1,cancer,I-Reason
108950,1,with,O
108950,1,mets,O
108950,1,to,O
108950,1,peritoneum,O
108950,1,on,O
108950,1,complicated,O
108950,1,by,O
108950,1,acites,O
108950,1,requiring,O
108950,1,14,O
108950,1,paracenteci,O
108950,1,since,O
108950,1,[,O
108950,1,**9-2**,O
108950,1,],O
108950,1,",",O
108950,1,on,O
108950,1,navelbine,B-Drug
108950,1,/,O
108950,1,avastin,B-Drug
108950,1,C2D13,O
108950,1,now,O
108950,1,presents,O
108950,1,wtih,O
108950,1,dyspnea,O
108950,1,and,O
108950,1,poor,O
108950,1,po,O
108950,1,intake,O
108950,1,.,O
108950,1,Patient,O
108950,1,noticed,O
108950,1,increased,O
108950,1,DOE,O
108950,1,over,O
108950,1,the,O
108950,1,last,O
108950,1,36,O
108950,1,hours,O
108950,1,with,O
108950,1,increased,O
108950,1,labored,O
108950,1,breathing,O
108950,1,while,O
108950,1,walking,O
108950,1,around,O
108950,1,the,O
108950,1,house,O
108950,1,and,O
108950,1,requiring,O
108950,1,assistance,O
108950,1,to,O
108950,1,even,O
108950,1,walk,O
108950,1,around,O
108950,1,the,O
108950,1,living,O
108950,1,room,O
108950,1,.,O
108950,1,Patient,O
108950,1,also,O
108950,1,reports,O
108950,1,increased,O
108950,1,nausea,O
108950,1,with,O
108950,1,vomitting,O
108950,1,7-10,O
108950,1,times,O
108950,1,over,O
108950,1,the,O
108950,1,last,O
108950,1,2,O
108950,1,days,O
108950,1,.,O
108950,1,Vomitius,O
108950,1,is,O
108950,1,nonbilious,O
108950,1,",",O
108950,1,and,O
108950,1,patient,O
108950,1,has,O
108950,1,been,O
108950,1,unable,O
108950,1,to,O
108950,1,tolerate,O
108950,1,po,O
108950,1,intake,O
108950,1,.,O
108950,1,Patient,O
108950,1,often,O
108950,1,has,O
108950,1,diarrhea,B-ADE
108950,1,related,O
108950,1,to,O
108950,1,Chemo,B-Drug
108950,1,",",O
108950,1,but,O
108950,1,reportedly,O
108950,1,no,O
108950,1,diarrhea,O
108950,1,since,O
108950,1,Tuesday,O
108950,1,.,O
108950,1,Patient,O
108950,1,was,O
108950,1,seen,O
108950,1,by,O
108950,1,VNA,O
108950,1,today,O
108950,1,and,O
108950,1,BP,O
108950,1,was,O
108950,1,60/p,O
108950,1,.,O
108950,1,EMS,O
108950,1,was,O
108950,1,called,O
108950,1,and,O
108950,1,on,O
108950,1,arrival,O
108950,1,BP,O
108950,1,was,O
108950,1,80/p,O
108950,1,.,O
108950,1,.,O
108950,1,In,O
108950,1,the,O
108950,1,ED,O
108950,1,",",O
108950,1,patient,O
108950,1,was,O
108950,1,noted,O
108950,1,to,O
108950,1,be,O
108950,1,hypotensive,B-Reason
108950,1,on,O
108950,1,arrival,O
108950,1,but,O
108950,1,improved,O
108950,1,with,O
108950,1,3,O
108950,1,L,O
108950,1,NS,B-Drug
108950,1,.,O
108950,1,Inital,O
108950,1,resident,O
108950,1,echo,O
108950,1,was,O
108950,1,concerning,O
108950,1,for,O
108950,1,pericardial,O
108950,1,effusion,O
108950,1,with,O
108950,1,collapse,O
108950,1,of,O
108950,1,RV,O
108950,1,",",O
108950,1,but,O
108950,1,formal,O
108950,1,TTE,O
108950,1,by,O
108950,1,Cardiology,O
108950,1,fellow,O
108950,1,showed,O
108950,1,no,O
108950,1,evidence,O
108950,1,of,O
108950,1,tamponade,O
108950,1,.,O
108950,1,LENIS,O
108950,1,were,O
108950,1,negative,O
108950,1,for,O
108950,1,DVT,O
108950,1,.,O
108950,1,CT,O
108950,1,head,O
108950,1,was,O
108950,1,negative,O
108950,1,.,O
108950,1,CXR,O
108950,1,was,O
108950,1,unremarkable,O
108950,1,.,O
108950,1,Vanco,B-Drug
108950,1,/,O
108950,1,Zosyn,B-Drug
108950,1,was,O
108950,1,given,O
108950,1,for,O
108950,1,initial,O
108950,1,concern,O
108950,1,of,O
108950,1,sepsis,B-Reason
108950,1,.,O
108950,1,Lytes,O
108950,1,were,O
108950,1,noteable,O
108950,1,for,O
108950,1,Na,O
108950,1,117,O
108950,1,down,O
108950,1,from,O
108950,1,122,O
108950,1,earlier,O
108950,1,in,O
108950,1,the,O
108950,1,month,O
108950,1,and,O
108950,1,Cr,O
108950,1,2.2,O
108950,1,from,O
108950,1,0.8,O
108950,1,.,O
108950,1,Also,O
108950,1,noted,O
108950,1,to,O
108950,1,be,O
108950,1,neutropenic,O
108950,1,.,O
108950,1,Patient,O
108950,1,refused,O
108950,1,central,O
108950,1,line,O
108950,2,and,O
108950,2,code,O
108950,2,status,O
108950,2,was,O
108950,2,reportedly,O
108950,2,DNR/I,O
108950,2,.,O
108950,2,.,O
108950,2,On,O
108950,2,the,O
108950,2,floor,O
108950,2,",",O
108950,2,patient,O
108950,2,reports,O
108950,2,chronic,O
108950,2,low,O
108950,2,back,O
108950,2,pain,O
108950,2,",",O
108950,2,and,O
108950,2,feels,O
108950,2,weak,O
108950,2,and,O
108950,2,fatigued,O
108950,2,",",O
108950,2,but,O
108950,2,otherwise,O
108950,2,feels,O
108950,2,well,O
108950,2,.,O
108950,2,.,O
108950,2,Review,O
108950,2,of,O
108950,2,systems,O
108950,2,:,O
108950,2,(,O
108950,2,+,O
108950,2,),O
108950,2,Per,O
108950,2,HPI,O
108950,2,(,O
108950,2,-,O
108950,2,),O
108950,2,Denies,O
108950,2,fever,O
108950,2,",",O
108950,2,chills,O
108950,2,",",O
108950,2,night,O
108950,2,sweats,O
108950,2,.,O
108950,2,Denies,O
108950,2,headache,O
108950,2,",",O
108950,2,sinus,O
108950,2,tenderness,O
108950,2,",",O
108950,2,rhinorrhea,O
108950,2,or,O
108950,2,congestion,O
108950,2,.,O
108950,2,Denies,O
108950,2,cough,O
108950,2,",",O
108950,2,shortness,O
108950,2,of,O
108950,2,breath,O
108950,2,",",O
108950,2,or,O
108950,2,wheezing,O
108950,2,.,O
108950,2,Denies,O
108950,2,chest,O
108950,2,pain,O
108950,2,",",O
108950,2,chest,O
108950,2,pressure,O
108950,2,",",O
108950,2,palpitations,O
108950,2,",",O
108950,2,or,O
108950,2,weakness,O
108950,2,.,O
108950,2,Denies,O
108950,2,constipation,O
108950,2,",",O
108950,2,abdominal,O
108950,2,pain,O
108950,2,",",O
108950,2,or,O
108950,2,changes,O
108950,2,in,O
108950,2,bowel,O
108950,2,habits,O
108950,2,.,O
108950,2,Denies,O
108950,2,dysuria,O
108950,2,",",O
108950,2,frequency,O
108950,2,",",O
108950,2,or,O
108950,2,urgency,O
108950,2,.,O
108950,2,Denies,O
108950,2,arthralgias,O
108950,2,or,O
108950,2,myalgias,O
108950,2,.,O
108950,2,Denies,O
108950,2,rashes,O
108950,2,or,O
108950,2,skin,O
108950,2,changes,O
108950,2,.,O
108950,2,Past,O
108950,2,Medical,O
108950,2,History,O
108950,2,:,O
108950,2,Past,O
108950,2,Medical,O
108950,2,History,O
108950,2,:,O
108950,2,Breast,O
108950,2,cancer,O
108950,2,-,O
108950,2,Diagnosed,O
108950,2,in,O
108950,2,[,O
108950,2,**2174**,O
108950,2,],O
108950,2,with,O
108950,2,an,O
108950,2,infiltrating,O
108950,2,lobular,O
108950,2,carcinoma,O
108950,2,grade,O
108950,2,II,O
108950,2,",",O
108950,2,1.7,O
108950,2,cm,O
108950,2,",",O
108950,2,multifocal,O
108950,2,",",O
108950,2,with,O
108950,2,13,O
108950,2,out,O
108950,2,of,O
108950,2,29,O
108950,2,lymph,O
108950,2,nodes,O
108950,2,positive,O
108950,2,.,O
108950,2,The,O
108950,2,tumor,O
108950,2,was,O
108950,2,ER,O
108950,2,positive,O
108950,2,",",O
108950,2,PR,O
108950,2,positive,O
108950,2,",",O
108950,2,and,O
108950,2,HER-2/neu,O
108950,2,negative,O
108950,2,by,O
108950,2,both,O
108950,2,IHC,O
108950,2,and,O
108950,2,FISH,O
108950,2,.,O
108950,2,She,O
108950,2,underwent,O
108950,2,adjuvant,O
108950,2,chemotherapy,B-Drug
108950,2,after,O
108950,2,completion,O
108950,2,of,O
108950,2,surgery,O
108950,2,with,O
108950,2,Adriamycin,B-Drug
108950,2,and,O
108950,2,Cytoxan,B-Drug
108950,2,followed,O
108950,2,by,O
108950,2,10,O
108950,2,weekly,O
108950,2,doses,O
108950,2,of,O
108950,2,Taxol,B-Drug
108950,2,.,O
108950,2,She,O
108950,2,received,O
108950,2,and,O
108950,2,completed,O
108950,2,chest,O
108950,2,wall,O
108950,2,radiation,O
108950,2,.,O
108950,2,She,O
108950,2,was,O
108950,2,then,O
108950,2,started,O
108950,2,on,O
108950,2,adjuvant,O
108950,2,Arimidex,B-Drug
108950,2,therapy,O
108950,2,.,O
108950,2,In,O
108950,2,[,O
108950,2,**2178-1-25**,O
108950,2,],O
108950,2,she,O
108950,2,developed,O
108950,2,right,O
108950,2,shoulder,O
108950,2,pain,O
108950,2,and,O
108950,2,pain,O
108950,2,in,O
108950,2,her,O
108950,2,upper,O
108950,2,abdomen,O
108950,2,.,O
108950,2,The,O
108950,2,abdominal,O
108950,2,pain,O
108950,2,prompted,O
108950,2,workup,O
108950,2,and,O
108950,2,apparently,O
108950,2,blood,O
108950,2,work,O
108950,2,showed,O
108950,2,a,O
108950,2,CA,O
108950,2,[,O
108950,2,**95**,O
108950,2,],O
108950,2,-29,O
108950,2,level,O
108950,2,of,O
108950,2,203,O
108950,2,.,O
108950,2,A,O
108950,2,PET,O
108950,2,scan,O
108950,2,revealed,O
108950,2,nodularity,O
108950,2,in,O
108950,2,her,O
108950,2,omentum,O
108950,2,consistent,O
108950,2,with,O
108950,2,metastatic,O
108950,2,disease,O
108950,2,.,O
108950,2,A,O
108950,2,bone,O
108950,2,scan,O
108950,2,reportedly,O
108950,2,was,O
108950,2,negative,O
108950,2,.,O
108950,2,She,O
108950,2,was,O
108950,2,started,O
108950,2,on,O
108950,2,high-dose,O
108950,2,Faslodex,B-Drug
108950,2,hormone,I-Drug
108950,2,treatment,O
108950,2,[,O
108950,2,**2178-3-12**,O
108950,2,],O
108950,2,and,O
108950,2,progressed,O
108950,2,on,O
108950,2,this,O
108950,2,in,O
108950,2,[,O
108950,2,**2178-7-25**,O
108950,2,],O
108950,2,.,O
108950,2,She,O
108950,2,was,O
108950,2,started,O
108950,2,on,O
108950,2,Xeloda,B-Drug
108950,2,in,O
108950,2,[,O
108950,2,**8-/2178**,O
108950,2,],O
108950,2,and,O
108950,2,continued,O
108950,2,and,O
108950,2,recently,O
108950,2,progressed,O
108950,2,with,O
108950,2,her,O
108950,2,last,O
108950,3,dose,O
108950,3,of,O
108950,3,Xeloda,B-Drug
108950,3,on,O
108950,3,[,O
108950,3,**2178-12-5**,O
108950,3,],O
108950,3,.,O
108950,3,-,O
108950,3,S/p,O
108950,3,Fulvestrant,B-Drug
108950,3,x7,O
108950,3,last,O
108950,3,given,O
108950,3,[,O
108950,3,**2178-9-16**,O
108950,3,],O
108950,3,-,O
108950,3,Temodar,B-Drug
108950,3,PARP,O
108950,3,Phase,O
108950,3,II,O
108950,3,Trial,O
108950,3,:,O
108950,3,Cycle,O
108950,3,#,O
108950,3,:,O
108950,3,1,O
108950,3,Day,O
108950,3,1,O
108950,3,:,O
108950,3,[,O
108950,3,**2179-1-13**,O
108950,3,],O
108950,3,",",O
108950,3,went,O
108950,3,off,O
108950,3,trial,O
108950,3,for,O
108950,3,for,O
108950,3,toxicity,B-ADE
108950,3,-,O
108950,3,VinORELbine,B-Drug
108950,3,(,I-Drug
108950,3,Navelbine,I-Drug
108950,3,),I-Drug
108950,3,40,O
108950,3,mg,O
108950,3,IV,O
108950,3,day,O
108950,3,1,O
108950,3,(,O
108950,3,[,O
108950,3,**2179-1-21**,O
108950,3,],O
108950,3,),O
108950,3,",",O
108950,3,held,O
108950,3,day,O
108950,3,8,O
108950,3,and,O
108950,3,15,O
108950,3,due,O
108950,3,to,O
108950,3,neutropenia,B-ADE
108950,3,.,O
108950,3,(,O
108950,3,30,O
108950,3,mg/m2,O
108950,3,-,O
108950,3,dose,O
108950,3,reduced,O
108950,3,by,O
108950,3,17,O
108950,3,%,O
108950,3,to,O
108950,3,25,O
108950,3,mg/m2,O
108950,3,),O
108950,3,.,O
108950,3,Other,O
108950,3,Past,O
108950,3,Medical,O
108950,3,History,O
108950,3,:,O
108950,3,1,O
108950,3,.,O
108950,3,Breast,O
108950,3,cancer,O
108950,3,as,O
108950,3,above,O
108950,3,2,O
108950,3,.,O
108950,3,Bladder,O
108950,3,suspension,O
108950,3,.,O
108950,3,3,O
108950,3,.,O
108950,3,GERD,O
108950,3,4,O
108950,3,.,O
108950,3,Osteoporosis,O
108950,3,.,O
108950,3,5,O
108950,3,.,O
108950,3,Left,O
108950,3,frozen,O
108950,3,shoulder,O
108950,3,.,O
108950,3,6,O
108950,3,.,O
108950,3,Depression,O
108950,3,and,O
108950,3,anxiety,O
108950,3,.,O
108950,3,7,O
108950,3,.,O
108950,3,Laparoscopic,O
108950,3,cholecystectomy,O
108950,3,.,O
108950,3,8,O
108950,3,.,O
108950,3,Rosacea,O
108950,3,.,O
108950,3,9,O
108950,3,.,O
108950,3,Hypothyroidism,O
108950,3,.,O
108950,3,10,O
108950,3,.,O
108950,3,Sleep,O
108950,3,apnea,O
108950,3,.,O
108950,3,11,O
108950,3,.,O
108950,3,Rheumatic,O
108950,3,fever,O
108950,3,with,O
108950,3,subsequent,O
108950,3,dental,O
108950,3,prophylaxis,O
108950,3,.,O
108950,3,12,O
108950,3,.,O
108950,3,Left,O
108950,3,eye,O
108950,3,surgery,O
108950,3,.,O
108950,3,Social,O
108950,3,History,O
108950,3,:,O
108950,3,She,O
108950,3,is,O
108950,3,divorced,O
108950,3,.,O
108950,3,She,O
108950,3,is,O
108950,3,a,O
108950,3,nonsmoker,O
108950,3,and,O
108950,3,drinks,O
108950,3,alcohol,O
108950,3,socially,O
108950,3,.,O
108950,3,She,O
108950,3,is,O
108950,3,retired,O
108950,3,and,O
108950,3,former,O
108950,3,employee,O
108950,3,of,O
108950,3,the,O
108950,3,Federal,O
108950,3,government,O
108950,3,.,O
108950,3,She,O
108950,3,is,O
108950,3,of,O
108950,3,Lithuanian,O
108950,3,origin,O
108950,3,.,O
108950,3,Family,O
108950,3,History,O
108950,3,:,O
108950,3,Her,O
108950,3,mother,O
108950,3,had,O
108950,3,breast,O
108950,3,cancer,O
108950,3,at,O
108950,3,age,O
108950,3,75,O
108950,3,and,O
108950,3,underwent,O
108950,3,lumpectomy,O
108950,3,and,O
108950,3,radiation,O
108950,3,therapy,O
108950,3,.,O
108950,3,Her,O
108950,3,maternal,O
108950,3,aunt,O
108950,3,had,O
108950,3,[,O
108950,3,**Name2,O
108950,3,(,O
108950,3,NI,O
108950,3,),O
108950,3,499**,O
108950,3,],O
108950,3,cancer,O
108950,3,in,O
108950,3,her,O
108950,3,70s,O
108950,3,.,O
108950,3,The,O
108950,3,patient,O
108950,3,'s,O
108950,3,sister,O
108950,3,had,O
108950,3,[,O
108950,3,**Name2,O
108950,3,(,O
108950,3,NI,O
108950,3,),O
108950,3,499**,O
108950,3,],O
108950,3,cancer,O
108950,3,at,O
108950,3,55,O
108950,3,and,O
108950,3,two,O
108950,3,paternal,O
108950,3,aunts,O
108950,3,with,O
108950,3,breast,O
108950,3,cancer,O
108950,3,at,O
108950,3,age,O
108950,3,52,O
108950,3,and,O
108950,3,70,O
108950,3,",",O
108950,3,a,O
108950,3,paternal,O
108950,3,first,O
108950,3,cousin,O
108950,3,had,O
108950,3,renal,O
108950,3,cancer,O
108950,3,.,O
108950,3,She,O
108950,3,has,O
108950,3,not,O
108950,3,undergone,O
108950,3,genetic,O
108950,3,testing,O
108950,3,.,O
108950,3,Physical,O
108950,3,Exam,O
108950,3,:,O
108950,3,Vitals,O
108950,3,:,O
108950,3,T,O
108950,3,:,O
108950,3,96.5,O
108950,3,BP,O
108950,3,:,O
108950,3,100/58,O
108950,3,P,O
108950,3,:,O
108950,3,116,O
108950,3,R:18,O
108950,3,O2,B-Drug
108950,3,:,O
108950,3,97,O
108950,3,%,O
108950,3,2L,O
108950,3,NC,O
108950,3,General,O
108950,3,:,O
108950,3,Markedly,O
108950,3,cachectic,O
108950,3,",",O
108950,3,tired,O
108950,3,appearing,O
108950,3,",",O
108950,3,pale,O
108950,3,",",O
108950,3,but,O
108950,3,NAD,O
108950,3,HEENT,O
108950,3,:,O
108950,3,Sclera,O
108950,3,anicteric,O
108950,3,",",O
108950,3,dry,O
108950,3,MM,O
108950,3,",",O
108950,3,oropharynx,O
108950,4,clear,O
108950,4,without,O
108950,4,thrush,O
108950,4,Neck,O
108950,4,:,O
108950,4,supple,O
108950,4,",",O
108950,4,JVP,O
108950,4,not,O
108950,4,elevated,O
108950,4,",",O
108950,4,no,O
108950,4,LAD,O
108950,4,Lungs,O
108950,4,:,O
108950,4,Clear,O
108950,4,to,O
108950,4,auscultation,O
108950,4,bilaterally,O
108950,4,",",O
108950,4,no,O
108950,4,wheezes,O
108950,4,",",O
108950,4,rales,O
108950,4,",",O
108950,4,ronchi,O
108950,4,CV,O
108950,4,:,O
108950,4,Regular,O
108950,4,rate,O
108950,4,and,O
108950,4,rhythm,O
108950,4,",",O
108950,4,normal,O
108950,4,S1,O
108950,4,+,O
108950,4,S2,O
108950,4,",",O
108950,4,no,O
108950,4,murmurs,O
108950,4,",",O
108950,4,rubs,O
108950,4,",",O
108950,4,gallops,O
108950,4,Abdomen,O
108950,4,:,O
108950,4,soft,O
108950,4,",",O
108950,4,non-tender,O
108950,4,",",O
108950,4,non-distended,O
108950,4,",",O
108950,4,bowel,O
108950,4,sounds,O
108950,4,present,O
108950,4,",",O
108950,4,no,O
108950,4,rebound,O
108950,4,tenderness,O
108950,4,or,O
108950,4,guarding,O
108950,4,",",O
108950,4,no,O
108950,4,organomegaly,O
108950,4,GU,O
108950,4,:,O
108950,4,no,O
108950,4,foley,O
108950,4,Ext,O
108950,4,:,O
108950,4,warm,O
108950,4,",",O
108950,4,well,O
108950,4,perfused,O
108950,4,",",O
108950,4,2+,O
108950,4,pulses,O
108950,4,",",O
108950,4,1+,O
108950,4,edema,O
108950,4,of,O
108950,4,ankles,O
108950,4,bilaterally,O
108950,4,",",O
108950,4,no,O
108950,4,clubbing,O
108950,4,",",O
108950,4,cyanosis,O
108950,4,Pertinent,O
108950,4,Results,O
108950,4,:,O
108950,4,[,O
108950,4,**2179-3-8**,O
108950,4,],O
108950,4,04:20PM,O
108950,4,BLOOD,O
108950,4,WBC-1.1*,O
108950,4,#,O
108950,4,RBC-3.85*,O
108950,4,Hgb-12.3,O
108950,4,Hct-34.8*,O
108950,4,MCV-91,O
108950,4,MCH-32.0,O
108950,4,MCHC-35.4*,O
108950,4,RDW-14.5,O
108950,4,Plt,O
108950,4,Ct-270,O
108950,4,[,O
108950,4,**2179-3-9**,O
108950,4,],O
108950,4,12:28AM,O
108950,4,BLOOD,O
108950,4,WBC-1.0*,O
108950,4,RBC-3.46*,O
108950,4,Hgb-11.2*,O
108950,4,Hct-32.3*,O
108950,4,MCV-93,O
108950,4,MCH-32.4*,O
108950,4,MCHC-34.7,O
108950,4,RDW-14.4,O
108950,4,Plt,O
108950,4,Ct-292,O
108950,4,[,O
108950,4,**2179-3-9**,O
108950,4,],O
108950,4,04:20AM,O
108950,4,BLOOD,O
108950,4,WBC-1.0*,O
108950,4,RBC-3.40*,O
108950,4,Hgb-10.8*,O
108950,4,Hct-31.3*,O
108950,4,MCV-92,O
108950,4,MCH-31.9,O
108950,4,MCHC-34.6,O
108950,4,RDW-14.7,O
108950,4,Plt,O
108950,4,Ct-268,O
108950,4,[,O
108950,4,**2179-3-10**,O
108950,4,],O
108950,4,03:04AM,O
108950,4,BLOOD,O
108950,4,WBC-1.2*,O
108950,4,RBC-3.30*,O
108950,4,Hgb-10.2*,O
108950,4,Hct-30.7*,O
108950,4,MCV-93,O
108950,4,MCH-31.0,O
108950,4,MCHC-33.4,O
108950,4,RDW-14.8,O
108950,4,Plt,O
108950,4,Ct-311,O
108950,4,[,O
108950,4,**2179-3-9**,O
108950,4,],O
108950,4,12:28AM,O
108950,4,BLOOD,O
108950,4,PT-11.3,O
108950,4,PTT-34.4,O
108950,4,INR,O
108950,4,(,O
108950,4,PT,O
108950,4,),O
108950,4,-0.9,O
108950,4,[,O
108950,4,**2179-3-8**,O
108950,4,],O
108950,4,04:20PM,O
108950,4,BLOOD,O
108950,4,Glucose-100,O
108950,4,UreaN-115*,O
108950,4,Creat-2.2*,O
108950,4,#,O
108950,4,Na-117*,O
108950,4,K-4.3,O
108950,4,Cl-71*,O
108950,4,HCO3-30,O
108950,4,AnGap-20,O
108950,4,[,O
108950,4,**2179-3-9**,O
108950,4,],O
108950,4,04:20AM,O
108950,4,BLOOD,O
108950,4,Glucose-95,O
108950,4,UreaN-88*,O
108950,4,Creat-1.5*,O
108950,4,Na-126*,O
108950,4,K-3.6,O
108950,4,Cl-86*,O
108950,4,HCO3-29,O
108950,4,AnGap-15,O
108950,4,[,O
108950,4,**2179-3-10**,O
108950,4,],O
108950,4,03:04AM,O
108950,4,BLOOD,O
108950,4,Glucose-96,O
108950,4,UreaN-71*,O
108950,4,Creat-1.1,O
108950,4,Na-130*,O
108950,4,K-3.4,O
108950,4,Cl-93*,O
108950,4,HCO3-27,O
108950,4,AnGap-13,O
108950,4,[,O
108950,4,**2179-3-9**,O
108950,4,],O
108950,4,04:20AM,O
108950,4,BLOOD,O
108950,4,CK,O
108950,4,(,O
108950,4,CPK,O
108950,4,),O
108950,4,-18*,O
108950,4,[,O
108950,4,**2179-3-9**,O
108950,4,],O
108950,4,02:37PM,O
108950,4,BLOOD,O
108950,4,CK,O
108950,4,(,O
108950,4,CPK,O
108950,4,),O
108950,4,-18*,O
108950,4,[,O
108950,4,**2179-3-10**,O
108950,4,],O
108950,4,03:04AM,O
108950,4,BLOOD,O
108950,4,CK,O
108950,4,(,O
108950,4,CPK,O
108950,4,),O
108950,4,-16*,O
108950,4,[,O
108950,4,**2179-3-9**,O
108950,4,],O
108950,4,04:20AM,O
108950,4,BLOOD,O
108950,4,CK-MB-2,O
108950,4,cTropnT-,O
108950,4,<,O
108950,4,0.01,O
108950,4,[,O
108950,4,**2179-3-9**,O
108950,4,],O
108950,4,02:37PM,O
108950,4,BLOOD,O
108950,4,CK-MB-NotDone,O
108950,4,cTropnT-,O
108950,4,<,O
108950,4,0.01,O
108950,4,[,O
108950,4,**2179-3-10**,O
108950,4,],O
108950,4,03:04AM,O
108950,4,BLOOD,O
108950,4,CK-MB-NotDone,O
108950,4,cTropnT-,O
108950,4,<,O
108950,4,0.01,O
108950,4,[,O
108950,4,**2179-3-8**,O
108950,4,],O
108950,4,04:20PM,O
108950,4,BLOOD,O
108950,4,proBNP-4631*,O
108950,4,.,O
108950,4,[,O
108950,4,**3-8**,O
108950,4,],O
108950,4,Echo,O
108950,4,:,O
108950,4,Overall,O
108950,4,left,O
108950,4,ventricular,O
108950,4,systolic,O
108950,4,function,O
108950,4,is,O
108950,4,normal,O
108950,4,(,O
108950,4,LVEF,O
108950,4,>,O
108950,4,55,O
108950,4,%,O
108950,4,),O
108950,4,.,O
108950,4,Due,O
108950,4,to,O
108950,4,suboptimal,O
108950,4,image,O
108950,4,quality,O
108950,4,and,O
108950,4,focused,O
108950,4,views,O
108950,4,",",O
108950,4,a,O
108950,4,focal,O
108950,4,wall,O
108950,4,motion,O
108950,5,abnormality,O
108950,5,can,O
108950,5,not,O
108950,5,be,O
108950,5,excluded..,O
108950,5,Right,O
108950,5,ventricular,O
108950,5,chamber,O
108950,5,size,O
108950,5,and,O
108950,5,free,O
108950,5,wall,O
108950,5,motion,O
108950,5,are,O
108950,5,normal,O
108950,5,.,O
108950,5,The,O
108950,5,aortic,O
108950,5,valve,O
108950,5,is,O
108950,5,not,O
108950,5,well,O
108950,5,seen,O
108950,5,.,O
108950,5,The,O
108950,5,mitral,O
108950,5,valve,O
108950,5,appears,O
108950,5,structurally,O
108950,5,normal,O
108950,5,with,O
108950,5,trivial,O
108950,5,mitral,O
108950,5,regurgitation,O
108950,5,.,O
108950,5,There,O
108950,5,is,O
108950,5,a,O
108950,5,very,O
108950,5,small,O
108950,5,pericardial,O
108950,5,effusion,O
108950,5,",",O
108950,5,primarily,O
108950,5,around,O
108950,5,the,O
108950,5,right,O
108950,5,atrium,O
108950,5,and,O
108950,5,basal,O
108950,5,right,O
108950,5,ventricle,O
108950,5,with,O
108950,5,no,O
108950,5,echocardiographic,O
108950,5,signs,O
108950,5,of,O
108950,5,tamponade,O
108950,5,.,O
108950,5,.,O
108950,5,[,O
108950,5,**3-8**,O
108950,5,],O
108950,5,CXR,O
108950,5,:,O
108950,5,(,O
108950,5,pending,O
108950,5,final,O
108950,5,read,O
108950,5,),O
108950,5,.,O
108950,5,[,O
108950,5,**3-8**,O
108950,5,],O
108950,5,LENIs,O
108950,5,:,O
108950,5,IMPRESSION,O
108950,5,:,O
108950,5,No,O
108950,5,evidence,O
108950,5,of,O
108950,5,DVT,O
108950,5,of,O
108950,5,either,O
108950,5,lower,O
108950,5,extremity,O
108950,5,.,O
108950,5,.,O
108950,5,[,O
108950,5,**3-8**,O
108950,5,],O
108950,5,Head,O
108950,5,CT,O
108950,5,:,O
108950,5,IMPRESSIONS,O
108950,5,:,O
108950,5,No,O
108950,5,acute,O
108950,5,intracranial,O
108950,5,abnormality,O
108950,5,.,O
108950,5,No,O
108950,5,evidence,O
108950,5,of,O
108950,5,intracranial,O
108950,5,mass,O
108950,5,",",O
108950,5,but,O
108950,5,MRI,O
108950,5,is,O
108950,5,more,O
108950,5,sensitive,O
108950,5,for,O
108950,5,the,O
108950,5,detection,O
108950,5,of,O
108950,5,intracranial,O
108950,5,lesions,O
108950,5,and,O
108950,5,should,O
108950,5,be,O
108950,5,considered,O
108950,5,.,O
108950,5,[,O
108950,5,**3-10**,O
108950,5,],O
108950,5,:,O
108950,5,KUB,O
108950,5,Moderate,O
108950,5,amount,O
108950,5,of,O
108950,5,ascites,O
108950,5,with,O
108950,5,largest,O
108950,5,pocket,O
108950,5,seen,O
108950,5,within,O
108950,5,the,O
108950,5,right,O
108950,5,lower,O
108950,5,quadrant,O
108950,5,.,O
108950,5,Multiple,O
108950,5,septations,O
108950,5,are,O
108950,5,noted,O
108950,5,compatible,O
108950,5,with,O
108950,5,component,O
108950,5,of,O
108950,5,loculation,O
108950,5,of,O
108950,5,the,O
108950,5,fluid,O
108950,5,.,O
108950,5,[,O
108950,5,**3-12**,O
108950,5,],O
108950,5,:,O
108950,5,Request,O
108950,5,for,O
108950,5,Pleurx,O
108950,5,catheterization,O
108950,5,for,O
108950,5,palliative,O
108950,5,peritoneal,O
108950,5,ascites,O
108950,5,drainage,O
108950,5,.,O
108950,5,1,O
108950,5,.,O
108950,5,Successful,O
108950,5,placement,O
108950,5,of,O
108950,5,Pleurx,O
108950,5,catheter,O
108950,5,in,O
108950,5,the,O
108950,5,right,O
108950,5,abdomen,O
108950,5,",",O
108950,5,with,O
108950,5,the,O
108950,5,tip,O
108950,5,terminating,O
108950,5,in,O
108950,5,the,O
108950,5,lower,O
108950,5,pelvis,O
108950,5,.,O
108950,5,2,O
108950,5,.,O
108950,5,Removal,O
108950,5,of,O
108950,5,one,O
108950,5,liter,O
108950,5,of,O
108950,5,yellow,O
108950,5,ascites,O
108950,5,fluid,O
108950,5,.,O
108950,5,.,O
108950,5,[,O
108950,5,**2179-3-13**,O
108950,5,],O
108950,5,05:23PM,O
108950,5,BLOOD,O
108950,5,WBC-5.4,O
108950,5,RBC-3.37*,O
108950,5,#,O
108950,5,Hgb-10.6*,O
108950,5,#,O
108950,5,Hct-33.4*,O
108950,5,#,O
108950,5,MCV-99*,O
108950,5,MCH-31.4,O
108950,5,MCHC-31.8,O
108950,5,RDW-14.5,O
108950,5,Plt,O
108950,5,Ct-434,O
108950,5,[,O
108950,5,**2179-3-13**,O
108950,5,],O
108950,5,05:12AM,O
108950,5,BLOOD,O
108950,5,Glucose-86,O
108950,5,UreaN-73*,O
108950,5,Creat-1.3*,O
108950,5,Na-145,O
108950,5,K-4.1,O
108950,5,Cl-114*,O
108950,5,HCO3-22,O
108950,5,AnGap-13,O
108950,5,[,O
108950,5,**2179-3-13**,O
108950,5,],O
108950,5,05:23PM,O
108950,5,BLOOD,O
108950,5,LD,O
108950,5,(,O
108950,5,LDH,O
108950,5,),O
108950,5,-132,O
108950,5,TotBili-1.0,O
108950,5,DirBili-0.4*,O
108950,5,IndBili-0.6,O
108950,5,[,O
108950,5,**2179-3-13**,O
108950,5,],O
108950,5,05:12AM,O
108950,5,BLOOD,O
108950,5,Calcium-10.2,O
108950,5,Phos-3.5,O
108950,5,Mg-1.9,O
108950,5,[,O
108950,5,**2179-3-11**,O
108950,5,],O
108950,5,02:48PM,O
108950,5,BLOOD,O
108950,5,CA27.29-744*,O
108950,5,[,O
108950,5,**2179-3-8**,O
108950,5,],O
108950,5,04:32PM,O
108950,5,BLOOD,O
108950,5,Lactate-1.6,O
108950,5,K-4.1,O
108950,5,Brief,O
108950,5,Hospital,O
108950,5,Course,O
108950,5,:,O
108950,5,Patient,O
108950,5,expired,O
108950,5,.,O
108950,5,69,O
108950,5,yo,O
108950,5,F,O
108950,5,with,O
108950,5,metastatic,O
108950,5,breast,O
108950,5,cancer,O
108950,5,prsents,O
108950,5,with,O
108950,5,vomitting,O
108950,5,",",O
108950,5,poor,O
108950,5,po,O
108950,5,intake,O
108950,5,and,O
108950,5,dyspnea,O
108950,5,and,O
108950,5,to,O
108950,5,be,O
108950,5,in,O
108950,5,acute,O
108950,5,renal,O
108950,5,failure,O
108950,5,with,O
108950,5,hyponatremia,O
108950,5,.,O
108950,6,Was,O
108950,6,tachycardic,O
108950,6,and,O
108950,6,complaining,O
108950,6,of,O
108950,6,mild,O
108950,6,chest,O
108950,6,tightness,O
108950,6,.,O
108950,6,Admitted,O
108950,6,to,O
108950,6,the,O
108950,6,ICU,O
108950,6,for,O
108950,6,tachycardia,O
108950,6,and,O
108950,6,hyponatremia,O
108950,6,",",O
108950,6,then,O
108950,6,to,O
108950,6,the,O
108950,6,oncology,O
108950,6,floor,O
108950,6,.,O
108950,6,See,O
108950,6,below,O
108950,6,for,O
108950,6,discussion,O
108950,6,of,O
108950,6,each,O
108950,6,issue,O
108950,6,.,O
108950,6,.,O
108950,6,Goals,O
108950,6,of,O
108950,6,care,O
108950,6,:,O
108950,6,meeting,O
108950,6,in,O
108950,6,ICU,O
108950,6,regarding,O
108950,6,goals,O
108950,6,of,O
108950,6,care,O
108950,6,and,O
108950,6,poor,O
108950,6,prognosis,O
108950,6,",",O
108950,6,then,O
108950,6,reiterated,O
108950,6,on,O
108950,6,the,O
108950,6,oncology,O
108950,6,medicine,O
108950,6,floor,O
108950,6,:,O
108950,6,Code,O
108950,6,:,O
108950,6,DNR/I,O
108950,6,(,O
108950,6,discussed,O
108950,6,with,O
108950,6,patient,O
108950,6,and,O
108950,6,HCP,O
108950,6,),O
108950,6,",",O
108950,6,and,O
108950,6,daughter,O
108950,6,HCP,O
108950,6,[,O
108950,6,**Name,O
108950,6,(,O
108950,6,NI,O
108950,6,),O
108950,6,**,O
108950,6,],O
108950,6,[,O
108950,6,**Telephone/Fax,O
108950,6,(,O
108950,6,1,O
108950,6,),O
108950,6,80568**,O
108950,6,],O
108950,6,.,O
108950,6,Focus,O
108950,6,on,O
108950,6,comfort,O
108950,6,with,O
108950,6,symptom,O
108950,6,management,O
108950,6,.,O
108950,6,Avoidance,O
108950,6,of,O
108950,6,invasive,O
108950,6,procedures,O
108950,6,",",O
108950,6,per,O
108950,6,family,O
108950,6,(,O
108950,6,son,O
108950,6,",",O
108950,6,daughter,O
108950,6,",",O
108950,6,sister,O
108950,6,),O
108950,6,.,O
108950,6,[,O
108950,6,**Name2,O
108950,6,(,O
108950,6,NI,O
108950,6,),O
108950,6,**,O
108950,6,],O
108950,6,died,O
108950,6,the,O
108950,6,morning,O
108950,6,after,O
108950,6,being,O
108950,6,transferred,O
108950,6,to,O
108950,6,the,O
108950,6,ICU,O
108950,6,.,O
108950,6,.,O
108950,6,#,O
108950,6,Altered,O
108950,6,mental,O
108950,6,status,O
108950,6,:,O
108950,6,Patient,O
108950,6,does,O
108950,6,not,O
108950,6,respond,O
108950,6,to,O
108950,6,verbal,O
108950,6,or,O
108950,6,visual,O
108950,6,stimuli,O
108950,6,on,O
108950,6,the,O
108950,6,floor,O
108950,6,.,O
108950,6,Likely,O
108950,6,d/t,O
108950,6,progressive,O
108950,6,metastatic,O
108950,6,disease,O
108950,6,",",O
108950,6,combined,O
108950,6,with,O
108950,6,renal,O
108950,6,failure,O
108950,6,",",O
108950,6,hypotension,O
108950,6,",",O
108950,6,pain,O
108950,6,",",O
108950,6,SBP,O
108950,6,infection,O
108950,6,",",O
108950,6,delirium,O
108950,6,.,O
108950,6,Pain,B-Reason
108950,6,controlled,O
108950,6,with,O
108950,6,IV,O
108950,6,morphine,B-Drug
108950,6,prn,O
108950,6,",",O
108950,6,treated,O
108950,6,SBP,B-Reason
108950,6,with,O
108950,6,ceftriaxone,B-Drug
108950,6,",",O
108950,6,palliative,O
108950,6,care,O
108950,6,following,O
108950,6,.,O
108950,6,.,O
108950,6,#,O
108950,6,Chest,O
108950,6,Pain,O
108950,6,:,O
108950,6,unclear,O
108950,6,etiology,O
108950,6,",",O
108950,6,seemed,O
108950,6,to,O
108950,6,be,O
108950,6,costrochondritis,O
108950,6,related,O
108950,6,as,O
108950,6,the,O
108950,6,pain,O
108950,6,was,O
108950,6,reproducible,O
108950,6,.,O
108950,6,Ruled,O
108950,6,out,O
108950,6,for,O
108950,6,MI,O
108950,6,with,O
108950,6,three,O
108950,6,sets,O
108950,6,of,O
108950,6,negative,O
108950,6,cardiac,O
108950,6,enzymes,O
108950,6,.,O
108950,6,A,O
108950,6,V/Q,O
108950,6,of,O
108950,6,her,O
108950,6,chest,O
108950,6,was,O
108950,6,ordered,O
108950,6,to,O
108950,6,rule,O
108950,6,out,O
108950,6,PE,O
108950,6,",",O
108950,6,but,O
108950,6,the,O
108950,6,patient,O
108950,6,was,O
108950,6,unable,O
108950,6,to,O
108950,6,lie,O
108950,6,flat,O
108950,6,and,O
108950,6,complete,O
108950,6,the,O
108950,6,exam,O
108950,6,so,O
108950,6,it,O
108950,6,was,O
108950,6,aborted,O
108950,6,.,O
108950,6,Held,O
108950,6,anticoagulation,O
108950,6,d/t,O
108950,6,goals,O
108950,6,of,O
108950,6,care,O
108950,6,",",O
108950,6,no,O
108950,6,CTA,O
108950,6,given,O
108950,6,ARF,O
108950,6,",",O
108950,6,could,O
108950,6,not,O
108950,6,tolerate,O
108950,6,V/Q,O
108950,6,scan,O
108950,6,.,O
108950,6,On,O
108950,6,the,O
108950,6,floor,O
108950,6,",",O
108950,6,patient,O
108950,6,unable,O
108950,6,to,O
108950,6,verbalize,O
108950,6,whether,O
108950,6,chest,O
108950,6,pain,O
108950,6,still,O
108950,6,present,O
108950,6,.,O
108950,6,Pain,O
108950,6,medications,O
108950,6,provided,O
108950,6,.,O
108950,6,.,O
108950,6,#,O
108950,6,Hypotenion/Tachycardia,O
108950,6,:,O
108950,6,likely,O
108950,6,was,O
108950,6,related,O
108950,6,to,O
108950,6,underlying,O
108950,6,cancer,O
108950,6,and,O
108950,6,hypovolemia,O
108950,6,.,O
108950,6,Was,O
108950,6,volume,O
108950,6,resuccitated,O
108950,6,with,O
108950,6,NS,B-Drug
108950,6,and,O
108950,6,the,O
108950,6,LR,B-Drug
108950,6,while,O
108950,6,in,O
108950,6,the,O
108950,6,ICU,O
108950,7,for,O
108950,7,the,O
108950,7,first,O
108950,7,two,O
108950,7,days,O
108950,7,.,O
108950,7,She,O
108950,7,was,O
108950,7,offerred,O
108950,7,a,O
108950,7,CVL,O
108950,7,in,O
108950,7,the,O
108950,7,ED,O
108950,7,and,O
108950,7,declined,O
108950,7,.,O
108950,7,Her,O
108950,7,BP,O
108950,7,improved,O
108950,7,to,O
108950,7,SBPs,O
108950,7,in,O
108950,7,the,O
108950,7,90s,O
108950,7,",",O
108950,7,then,O
108950,7,100s,O
108950,7,with,O
108950,7,IVFs,B-Drug
108950,7,and,O
108950,7,remained,O
108950,7,stable,O
108950,7,.,O
108950,7,Initially,O
108950,7,she,O
108950,7,seemed,O
108950,7,fluid,O
108950,7,responsive,O
108950,7,with,O
108950,7,a,O
108950,7,decrease,O
108950,7,in,O
108950,7,rate,O
108950,7,from,O
108950,7,130s,O
108950,7,to,O
108950,7,110s,O
108950,7,(,O
108950,7,which,O
108950,7,seemed,O
108950,7,to,O
108950,7,be,O
108950,7,her,O
108950,7,baseline,O
108950,7,),O
108950,7,.,O
108950,7,She,O
108950,7,remained,O
108950,7,tachycardic,O
108950,7,on,O
108950,7,day,O
108950,7,two,O
108950,7,of,O
108950,7,admission,O
108950,7,without,O
108950,7,an,O
108950,7,obvious,O
108950,7,cause,O
108950,7,as,O
108950,7,she,O
108950,7,seemed,O
108950,7,mostly,O
108950,7,fluid,O
108950,7,repleted,O
108950,7,.,O
108950,7,We,O
108950,7,continued,O
108950,7,to,O
108950,7,bolus,O
108950,7,her,O
108950,7,and,O
108950,7,pursued,O
108950,7,a,O
108950,7,further,O
108950,7,workup,O
108950,7,for,O
108950,7,PE,O
108950,7,.,O
108950,7,Initially,O
108950,7,she,O
108950,7,had,O
108950,7,negative,O
108950,7,LENIs,O
108950,7,and,O
108950,7,a,O
108950,7,CT,O
108950,7,was,O
108950,7,deferred,O
108950,7,because,O
108950,7,of,O
108950,7,ARF,O
108950,7,.,O
108950,7,A,O
108950,7,V/Q,O
108950,7,scan,O
108950,7,was,O
108950,7,performed,O
108950,7,on,O
108950,7,[,O
108950,7,**2179-3-10**,O
108950,7,],O
108950,7,",",O
108950,7,but,O
108950,7,she,O
108950,7,was,O
108950,7,unable,O
108950,7,to,O
108950,7,lie,O
108950,7,flat,O
108950,7,for,O
108950,7,the,O
108950,7,test,O
108950,7,and,O
108950,7,the,O
108950,7,test,O
108950,7,could,O
108950,7,not,O
108950,7,be,O
108950,7,completed,O
108950,7,.,O
108950,7,She,O
108950,7,was,O
108950,7,bolused,O
108950,7,periodically,O
108950,7,overnight,O
108950,7,to,O
108950,7,maintain,O
108950,7,MAP,O
108950,7,of,O
108950,7,over,O
108950,7,65,O
108950,7,.,O
108950,7,Her,O
108950,7,tachycardia,O
108950,7,improved,O
108950,7,with,O
108950,7,IVF,B-Drug
108950,7,boluses,O
108950,7,prn,O
108950,7,.,O
108950,7,.,O
108950,7,#,O
108950,7,Hyponatremia/Acute,O
108950,7,renal,O
108950,7,failure,O
108950,7,:,O
108950,7,Based,O
108950,7,on,O
108950,7,exam,O
108950,7,and,O
108950,7,history,O
108950,7,",",O
108950,7,likely,O
108950,7,hypovolemic,O
108950,7,hyponatremia,O
108950,7,.,O
108950,7,Most,O
108950,7,likely,O
108950,7,Gi,O
108950,7,losses,O
108950,7,combined,O
108950,7,with,O
108950,7,third,O
108950,7,spacing,O
108950,7,in,O
108950,7,the,O
108950,7,setting,O
108950,7,of,O
108950,7,ascites,O
108950,7,.,O
108950,7,With,O
108950,7,fluid,O
108950,7,resuccitation,O
108950,7,",",O
108950,7,she,O
108950,7,corrected,O
108950,7,and,O
108950,7,normalized,O
108950,7,very,O
108950,7,quickly,O
108950,7,but,O
108950,7,did,O
108950,7,not,O
108950,7,have,O
108950,7,any,O
108950,7,neurological,O
108950,7,changes,O
108950,7,.,O
108950,7,She,O
108950,7,did,O
108950,7,have,O
108950,7,a,O
108950,7,CT,O
108950,7,head,O
108950,7,in,O
108950,7,the,O
108950,7,ED,O
108950,7,that,O
108950,7,showed,O
108950,7,no,O
108950,7,intracranial,O
108950,7,lesions,O
108950,7,to,O
108950,7,explain,O
108950,7,this,O
108950,7,.,O
108950,7,Her,O
108950,7,ARF,B-Reason
108950,7,also,O
108950,7,improved,O
108950,7,with,O
108950,7,IVFs,B-Drug
108950,7,and,O
108950,7,her,O
108950,7,urine,O
108950,7,output,O
108950,7,remained,O
108950,7,brisk,O
108950,7,throughout,O
108950,7,her,O
108950,7,hospitalization,O
108950,7,.,O
108950,7,.,O
108950,7,#,O
108950,7,Thrush,O
108950,7,:,O
108950,7,Likely,O
108950,7,due,O
108950,7,to,O
108950,7,poor,O
108950,7,po,O
108950,7,intake,O
108950,7,and,O
108950,7,nausea/vomitting,O
108950,7,.,O
108950,7,Started,O
108950,7,swish,O
108950,7,and,O
108950,7,swallow,O
108950,7,for,O
108950,7,her,O
108950,7,comfort,O
108950,7,.,O
108950,7,.,O
108950,7,#,O
108950,7,Breast,B-Reason
108950,7,Cancer,I-Reason
108950,7,:,O
108950,7,mid-cycle,O
108950,7,in,O
108950,7,her,O
108950,7,avastin,B-Drug
108950,7,and,O
108950,7,navelbine,B-Drug
108950,7,.,O
108950,7,Is,O
108950,7,metastatic,O
108950,7,and,O
108950,7,has,O
108950,7,recurrent,O
108950,7,ascites,O
108950,7,requiring,O
108950,7,taps,O
108950,7,.,O
108950,7,On,O
108950,7,presentation,O
108950,7,",",O
108950,7,her,O
108950,7,abdomen,O
108950,7,was,O
108950,7,soft,O
108950,7,and,O
108950,7,a,O
108950,7,therapeutic,O
108950,7,paracentesis,O
108950,7,was,O
108950,7,deferred,O
108950,7,because,O
108950,7,of,O
108950,7,her,O
108950,7,hypovolemia,O
108950,7,",",O
108950,7,moderate,O
108950,7,hypotension,O
108950,7,and,O
108950,7,neutropenia,O
108950,7,.,O
108950,7,Oncology,O
108950,7,was,O
108950,8,consulted,O
108950,8,and,O
108950,8,followed,O
108950,8,along,O
108950,8,.,O
108950,8,Patient,O
108950,8,to,O
108950,8,oncology,O
108950,8,floor,O
108950,8,",",O
108950,8,outpatient,O
108950,8,oncology,O
108950,8,attending,O
108950,8,described,O
108950,8,poor,O
108950,8,prognosis,O
108950,8,.,O
108950,8,Family,O
108950,8,meeting,O
108950,8,regarding,O
108950,8,poor,O
108950,8,prognosis,O
108950,8,and,O
108950,8,goals,O
108950,8,of,O
108950,8,care,O
108950,8,;,O
108950,8,patient,O
108950,8,not,O
108950,8,to,O
108950,8,have,O
108950,8,further,O
108950,8,chemotherapy,B-Drug
108950,8,or,O
108950,8,interventions/invasive,O
108950,8,procedures,O
108950,8,.,O
108950,8,.,O
108950,8,#,O
108950,8,Leukopenia,B-ADE
108950,8,:,O
108950,8,Likely,O
108950,8,chemo,B-Drug
108950,8,related,O
108950,8,",",O
108950,8,as,O
108950,8,last,O
108950,8,dose,O
108950,8,was,O
108950,8,[,O
108950,8,**3-1**,O
108950,8,],O
108950,8,.,O
108950,8,ANC,O
108950,8,600,O
108950,8,so,O
108950,8,not,O
108950,8,yet,O
108950,8,neutropenic,O
108950,8,and,O
108950,8,never,O
108950,8,needed,O
108950,8,to,O
108950,8,be,O
108950,8,on,O
108950,8,neutropenic,O
108950,8,precautions,O
108950,8,.,O
108950,8,On,O
108950,8,3,O
108950,8,18,O
108950,8,",",O
108950,8,her,O
108950,8,WBC,O
108950,8,began,O
108950,8,to,O
108950,8,recover,O
108950,8,.,O
108950,8,.,O
108950,8,#,O
108950,8,Pleurex,O
108950,8,catheter,O
108950,8,placed,O
108950,8,to,O
108950,8,help,O
108950,8,with,O
108950,8,paracentesis/ascites,O
108950,8,drainage,O
108950,8,.,O
108950,8,SBP,B-Reason
108950,8,treated,O
108950,8,with,O
108950,8,ceftriaxone,B-Drug
108950,8,.,O
108950,8,Medications,O
108950,8,on,O
108950,8,Admission,O
108950,8,:,O
108950,8,#,O
108950,8,Octreotide,B-Drug
108950,8,Acetate,I-Drug
108950,8,100,O
108950,8,mcg,O
108950,8,SQ,O
108950,8,[,O
108950,8,**Hospital1,O
108950,8,**,O
108950,8,],O
108950,8,#,O
108950,8,Morphine,B-Drug
108950,8,15,O
108950,8,mg,O
108950,8,Tablet,O
108950,8,Sig,O
108950,8,:,O
108950,8,1-2,O
108950,8,Tablets,O
108950,8,PO,O
108950,8,Q6H,O
108950,8,#,O
108950,8,Levothyroxine,B-Drug
108950,8,50,O
108950,8,mcg,O
108950,8,Tablet,O
108950,8,Sig,O
108950,8,:,O
108950,8,One,O
108950,8,(,O
108950,8,1,O
108950,8,),O
108950,8,Tablet,O
108950,8,PO,O
108950,8,DAILY,O
108950,8,#,O
108950,8,Multivitamin,B-Drug
108950,8,po,O
108950,8,daily,O
108950,8,#,O
108950,8,Lorazepam,B-Drug
108950,8,0.5,O
108950,8,mg,O
108950,8,PO,O
108950,8,Q4H,O
108950,8,prn,O
108950,8,nausea,B-Reason
108950,8,#,O
108950,8,Loperamide,B-Drug
108950,8,2,O
108950,8,mg,O
108950,8,po,O
108950,8,QID,O
108950,8,prn,O
108950,8,#,O
108950,8,Diphenoxylate-Atropine,B-Drug
108950,8,2.5-0.025,O
108950,8,mg,O
108950,8,Tablet,O
108950,8,Sig,O
108950,8,:,O
108950,8,One,O
108950,8,(,O
108950,8,1,O
108950,8,),O
108950,8,Tablet,O
108950,8,PO,O
108950,8,Q6H,O
108950,8,prn,O
108950,8,#,O
108950,8,Nexium,B-Drug
108950,8,20,O
108950,8,mg,O
108950,8,daily,O
108950,8,#,O
108950,8,Ondansetron,B-Drug
108950,8,8,O
108950,8,mg,O
108950,8,Q8H,O
108950,8,prn,O
108950,8,#,O
108950,8,Compazine,B-Drug
108950,8,10,O
108950,8,mg,O
108950,8,po,O
108950,8,Q6H,O
108950,8,prn,O
108950,8,#,O
108950,8,Lidocaine,B-Drug
108950,8,5,O
108950,8,%,O
108950,8,(,O
108950,8,700,O
108950,8,mg/patch,O
108950,8,),O
108950,8,Adhesive,O
108950,8,Patch,O
108950,8,",",O
108950,8,Medicated,O
108950,8,Sig,O
108950,8,:,O
108950,8,One,O
108950,8,(,O
108950,8,1,O
108950,8,),O
108950,8,Adhesive,O
108950,8,Patch,O
108950,8,",",O
108950,8,Medicated,O
108950,8,Topical,O
108950,8,DAILY,O
108950,8,(,O
108950,8,Daily,O
108950,8,#,O
108950,8,NYSTATIN,B-Drug
108950,8,-,O
108950,8,"100,000",O
108950,8,unit/mL,O
108950,8,Suspension,O
108950,8,-,O
108950,8,4,O
108950,8,mL,O
108950,8,by,O
108950,8,mouth,O
108950,8,four,O
108950,8,times,O
108950,8,daily,O
108950,8,as,O
108950,8,needed,O
108950,8,for,O
108950,8,thrush,B-Reason
108950,8,swish,O
108950,8,and,O
108950,8,swallow,O
108950,8,#,O
108950,8,SUCRALFATE,B-Drug
108950,8,-,O
108950,8,1,O
108950,8,gram/10,O
108950,8,mL,O
108950,8,Suspension,O
108950,8,-,O
108950,8,10,O
108950,8,ml,O
108950,8,by,O
108950,8,mouth,O
108950,8,as,O
108950,8,needed,O
108950,8,Discharge,O
108950,8,Medications,O
108950,8,:,O
108950,8,n/a,O
108950,8,Discharge,O
108950,8,Disposition,O
108950,8,:,O
108950,8,Expired,O
108950,8,Discharge,O
108950,8,Diagnosis,O
108950,8,:,O
108950,8,Primary,O
108950,8,:,O
108950,8,Spontaneous,O
108950,8,bacterial,O
108950,8,peritonitis,O
108950,8,Secondary,O
108950,8,:,O
108950,8,Metastatic,O
108950,8,breast,O
108950,8,cancer,O
108950,8,Discharge,O
108950,8,Condition,O
108950,8,:,O
108950,8,Patient,O
108950,8,expired,O
108950,8,.,O
108950,8,Discharge,O
108950,8,Instructions,O
108950,8,:,O
108950,8,Patient,O
108950,8,expired,O
108950,8,.,O
108950,8,Followup,O
108950,8,Instructions,O
108950,8,:,O
108950,8,Patient,O
108950,8,expired,O
108950,8,.,O
108950,8,Completed,O
108950,8,by,O
108950,8,:,O
108950,8,[,O
108950,8,**2179-3-20**,O
108950,8,],O
